(NASDAQ:CELH), SAN DIEGO, Jan. 20, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Celsius Holdings, Inc. (NASDAQ: CELH) stock or sellers of Celsius puts between February 29, 2024 and September 4, 2024, inclusive (the “Class Period”), have until this upcoming Tuesday, January 21, 2025 to […]

The exercise period for warrants series TO 2 (the “Warrant Programme”) in Immunovia AB (publ) (“Immunovia” or the “Company”) ended on 16 January 2025. A total of 92,197,387 warrants were exercised for the subscription of 92,197,387 new shares, corresponding to an exercise rate of approximately 74.1 percent. Thus, no guarantee commitments need to be utilized.

The global police and law enforcement equipment market size is estimated to grow by USD 1.45 billion from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 6.83% during the forecast period.The report provides a comprehensive forecast of key segments below- https://mma.prnewswire.com/media/2600552/IRTNTR74736_bw2.jpg Segmentation Overview — Application — 1.1

Korea Zinc has announced that the National Pension Service (NPS) has decided on its voting direction for Korea Zinc's Extraordinary General Meeting (EGM). As the world's third-largest pension fund and Korea's representative public pension, this decision will no doubt carry substantial significance. https://mma.prnewswire.com/media/2479692/01_Logo.jpg On the 17th, the NPS Trustee Responsibility Committee convened and decided to

Unite Leading Tech Enterprises to Accelerate Innovation & Growth HKBN Enterprise Solutions today hosted the launch ceremony for the “HKBN InnoTech Ecosystem Alliance (HKBNiTEA) “, marking an important milestone in the company's push for digital transformation and technological innovation. Bringing together key leaders from the innovation and technology sectors, this alliance will synergise resources and

The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. (NASDAQ: PCRX). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of PCRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Pacira

The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/regeneron-pharmaceuticals-inc-loss-submission-form/?id=123378&from=4 CLASS

The Gross Law Firm issues the following notice to shareholders ofBioAge Labs, Inc. (NASDAQ: BIOA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of BIOA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/bioage-labs-inc-loss-submission-form/?id=123377&from=4 CLASS PERIOD:

The Gross Law Firm issues the following notice to shareholders of Micron Technology, Inc. (NASDAQ: MU). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of MU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/micron-technology-inc-loss-submission-form/?id=123376&from=4 CLASS

The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/revance-therapeutics-inc-loss-submission-form-2/?id=123375&from=4 CLASS